
CareTrust REIT (CTRE) Stock Forecast & Price Target
CareTrust REIT (CTRE) Analyst Ratings
Bulls say
CareTrust REIT has significantly expanded its structured finance portfolio from $15 million in early 2022 to $871 million, which strengthens operator relationships and diversifies revenue sources. The company's core portfolio is exhibiting a recovery, supported by strong corporate guarantees on leases, while the operator environment has stabilized, enhancing prospects for capital deployment. The performance of similar healthcare-focused REITs, exhibiting average same-store NOI growth of 22%, indicates a robust market landscape that suggests CareTrust REIT is well-positioned for continued growth and profitability.
Bears say
CareTrust REIT is facing a negative outlook due to a projected decline in cash collections by approximately 5%, attributed to a lower growth outlook and potential increases in competition driving property prices higher, which may adversely affect profitability. The anticipated slowdown in investment activity could reduce total investments to around $1 billion, coupled with the concern that the CA 525 bill may negatively impact operators' profitability and exert pressure on CareTrust's rent revenues. Furthermore, potential new tenant issues and tightening capital market conditions could lead to decreased liquidity, negatively affecting cash investments and overall valuations in the healthcare real estate sector.
This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.
CareTrust REIT (CTRE) Analyst Forecast & Price Prediction
Start investing in CareTrust REIT (CTRE)
Order type
Buy in
Order amount
Est. shares
0 shares